Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Research ArticleNeurology

Determining Amyloid-β Positivity Using 18F-AZD4694 PET Imaging

Joseph Therriault, Andrea L. Benedet, Tharick A. Pascoal, Melissa Savard, Nicholas J. Ashton, Mira Chamoun, Cecile Tissot, Firoza Lussier, Min Su Kang, Gleb Bezgin, Tina Wang, Jaime Fernandes-Arias, Gassan Massarweh, Paolo Vitali, Henrik Zetterberg, Kaj Blennow, Paramita Saha-Chaudhuri, Jean-Paul Soucy, Serge Gauthier and Pedro Rosa-Neto
Journal of Nuclear Medicine February 2021, 62 (2) 247-252; DOI: https://doi.org/10.2967/jnumed.120.245209
Joseph Therriault
1Translational Neuroimaging Laboratory, McGill University Research Centre for Studies in Aging, Douglas Hospital, McGill University, Montreal, Quebec, Canada
2Department of Neurology and Neurosurgery, McGill University, Montreal, Quebec, Canada
3Montreal Neurological Institute, Montreal, Quebec, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andrea L. Benedet
1Translational Neuroimaging Laboratory, McGill University Research Centre for Studies in Aging, Douglas Hospital, McGill University, Montreal, Quebec, Canada
2Department of Neurology and Neurosurgery, McGill University, Montreal, Quebec, Canada
3Montreal Neurological Institute, Montreal, Quebec, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tharick A. Pascoal
1Translational Neuroimaging Laboratory, McGill University Research Centre for Studies in Aging, Douglas Hospital, McGill University, Montreal, Quebec, Canada
2Department of Neurology and Neurosurgery, McGill University, Montreal, Quebec, Canada
3Montreal Neurological Institute, Montreal, Quebec, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Melissa Savard
1Translational Neuroimaging Laboratory, McGill University Research Centre for Studies in Aging, Douglas Hospital, McGill University, Montreal, Quebec, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nicholas J. Ashton
4Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, University of Gothenburg, Mölndal, Sweden
5Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mira Chamoun
1Translational Neuroimaging Laboratory, McGill University Research Centre for Studies in Aging, Douglas Hospital, McGill University, Montreal, Quebec, Canada
2Department of Neurology and Neurosurgery, McGill University, Montreal, Quebec, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Cecile Tissot
1Translational Neuroimaging Laboratory, McGill University Research Centre for Studies in Aging, Douglas Hospital, McGill University, Montreal, Quebec, Canada
2Department of Neurology and Neurosurgery, McGill University, Montreal, Quebec, Canada
3Montreal Neurological Institute, Montreal, Quebec, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Firoza Lussier
1Translational Neuroimaging Laboratory, McGill University Research Centre for Studies in Aging, Douglas Hospital, McGill University, Montreal, Quebec, Canada
2Department of Neurology and Neurosurgery, McGill University, Montreal, Quebec, Canada
3Montreal Neurological Institute, Montreal, Quebec, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Min Su Kang
1Translational Neuroimaging Laboratory, McGill University Research Centre for Studies in Aging, Douglas Hospital, McGill University, Montreal, Quebec, Canada
2Department of Neurology and Neurosurgery, McGill University, Montreal, Quebec, Canada
3Montreal Neurological Institute, Montreal, Quebec, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gleb Bezgin
1Translational Neuroimaging Laboratory, McGill University Research Centre for Studies in Aging, Douglas Hospital, McGill University, Montreal, Quebec, Canada
2Department of Neurology and Neurosurgery, McGill University, Montreal, Quebec, Canada
3Montreal Neurological Institute, Montreal, Quebec, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tina Wang
1Translational Neuroimaging Laboratory, McGill University Research Centre for Studies in Aging, Douglas Hospital, McGill University, Montreal, Quebec, Canada
2Department of Neurology and Neurosurgery, McGill University, Montreal, Quebec, Canada
3Montreal Neurological Institute, Montreal, Quebec, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jaime Fernandes-Arias
1Translational Neuroimaging Laboratory, McGill University Research Centre for Studies in Aging, Douglas Hospital, McGill University, Montreal, Quebec, Canada
2Department of Neurology and Neurosurgery, McGill University, Montreal, Quebec, Canada
3Montreal Neurological Institute, Montreal, Quebec, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gassan Massarweh
3Montreal Neurological Institute, Montreal, Quebec, Canada
6Department of Radiochemistry, McGill University, Montreal, Quebec, Canada; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Paolo Vitali
2Department of Neurology and Neurosurgery, McGill University, Montreal, Quebec, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Henrik Zetterberg
4Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, University of Gothenburg, Mölndal, Sweden
5Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kaj Blennow
4Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, University of Gothenburg, Mölndal, Sweden
5Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Paramita Saha-Chaudhuri
7Department of Epidemiology and Biostatistics, McGill University, Montreal, Quebec, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jean-Paul Soucy
2Department of Neurology and Neurosurgery, McGill University, Montreal, Quebec, Canada
3Montreal Neurological Institute, Montreal, Quebec, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Serge Gauthier
1Translational Neuroimaging Laboratory, McGill University Research Centre for Studies in Aging, Douglas Hospital, McGill University, Montreal, Quebec, Canada
2Department of Neurology and Neurosurgery, McGill University, Montreal, Quebec, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Pedro Rosa-Neto
1Translational Neuroimaging Laboratory, McGill University Research Centre for Studies in Aging, Douglas Hospital, McGill University, Montreal, Quebec, Canada
2Department of Neurology and Neurosurgery, McGill University, Montreal, Quebec, Canada
3Montreal Neurological Institute, Montreal, Quebec, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • Additional Files
  • FIGURE 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 1.

    Transaxial (top) and midsagittal (bottom) representative 18F-AZD4694 SUVR PET images of 4 subjects representing range of binding patterns in present study. All images are presented in template space. MNI coordinates: x = 2, y = −59, z = 15. CDR = Clinical Dementia Rating; MMSE = Mini-Mental State Examination.

  • FIGURE 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 2.

    Means and SDs (error bars) in 18F-AZD4694 PET SUVR for CU young adults (age < 25 y), CU elderly, and CI groups. Young adults displayed minimal amyloid PET uptake (mean, 1.14; SD, 0.09). Dashed line represents 2 SDs above mean of young adults, at 1.33 18F-AZD4694 SUVR.

  • FIGURE 3.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 3.

    ROC curves contrasting visually positive vs. negative cases. (A) When contrasting CU elderly with AD dementia groups, we observed good AUC (82.5%; sensitivity, 85%; specificity, 73%). (B) Optimal threshold at this point was 1.56 SUVR, represented by dashed line. (C) Area under ROC curve contrasting visually negative vs. visually positive cases displayed excellent AUC (97%; sensitivity, 90.91%; specificity, 95%). (D) 18F-AZD4694 PET means are shown for visually positive (red) and visually negative (blue) groups, with dashed line representing optimal threshold derived from ROC curve (1.55 SUVR).

  • FIGURE 4.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 4.

    Gaussian mixture modeling representing 2 distributions. Low 18F-AZD4694 (red) and high 18F-AZD4694 (green) gaussian distributions are superimposed on subject density histogram for all 18F-AZD4694 PET SUVRs from CU elderly and CI populations. Optimal cut point from gaussian mixture modeling was 1.55 SUVR.

  • FIGURE 5.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 5.

    ROC curves contrasting CSF-positive vs. -negative individuals. (A) Area under ROC curve contrasting individuals dichotomized on basis of their cerebrospinal measure of Aβ42/Aβ40 ratio. This method resulted in area under ROC curve of 95% (sensitivity, 88.9%; specificity, 91.4%). (B) AZD4694 PET means are shown for CSF-negative (blue) and CSF-positive (red) individuals, with dashed line representing optimal threshold derived from ROC curve (1.51 SUVR).

Tables

  • Figures
  • Additional Files
    • View popup
    TABLE 1

    Demographic, Clinical, and Biomarker Characteristics of Sample

    P*
    CharacteristicCU youngCU elderlyCICU youngvs.CU elderlyCU elderlyvs.CI
    Total patients (n)228965——
    Mean age (y)22.7 (SD, 1.3)72.33 (SD, 5.88)67.91 (SD, 8.97)<0.00010.0004
    Female (n)14 (63%)51 (57%)36 (55%)0.590.81
    Mean education (y)16.61 (SD, 1.33)15.06 (SD, 3.81)15.1 (SD, 3.34)0.060.94
    APOEε4 carriers (n)6 (27%)33 (37%)41 (63%)0.58<0.0001
    Mean MMSE29.77 (SD, 0.53)29.12 (SD, 1.07)24.03 (SD, 6.07)0.009<0.0001
    Mean neocortical 18F-AZD4694 SUVR1.14 (SD, 0.09)1.48 (0.38)2.04 (SD, 0.57)<0.0001<0.0001
    Mean CSF Aβ42/Aβ400.09 (SD, 0.006)0.07 (SD, 0.02)0.05 (SD, 0.02)<0.0001<0.0001
    • ↵* Assessed with 2-sided independent-samples t tests for each variable except sex and APOEε4 status, for which contingency χ2 tests were performed.

    • MMSE = Mini-Mental State Examination.

Additional Files

  • Figures
  • Tables
  • Supplemental Data

    Files in this Data Supplement:

    • Supplemental Data
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 62 (2)
Journal of Nuclear Medicine
Vol. 62, Issue 2
February 1, 2021
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Determining Amyloid-β Positivity Using 18F-AZD4694 PET Imaging
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Determining Amyloid-β Positivity Using 18F-AZD4694 PET Imaging
Joseph Therriault, Andrea L. Benedet, Tharick A. Pascoal, Melissa Savard, Nicholas J. Ashton, Mira Chamoun, Cecile Tissot, Firoza Lussier, Min Su Kang, Gleb Bezgin, Tina Wang, Jaime Fernandes-Arias, Gassan Massarweh, Paolo Vitali, Henrik Zetterberg, Kaj Blennow, Paramita Saha-Chaudhuri, Jean-Paul Soucy, Serge Gauthier, Pedro Rosa-Neto
Journal of Nuclear Medicine Feb 2021, 62 (2) 247-252; DOI: 10.2967/jnumed.120.245209

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Determining Amyloid-β Positivity Using 18F-AZD4694 PET Imaging
Joseph Therriault, Andrea L. Benedet, Tharick A. Pascoal, Melissa Savard, Nicholas J. Ashton, Mira Chamoun, Cecile Tissot, Firoza Lussier, Min Su Kang, Gleb Bezgin, Tina Wang, Jaime Fernandes-Arias, Gassan Massarweh, Paolo Vitali, Henrik Zetterberg, Kaj Blennow, Paramita Saha-Chaudhuri, Jean-Paul Soucy, Serge Gauthier, Pedro Rosa-Neto
Journal of Nuclear Medicine Feb 2021, 62 (2) 247-252; DOI: 10.2967/jnumed.120.245209
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Abstract
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • CONCLUSION
    • DISCLOSURE
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • PDF

Related Articles

  • This Month in JNM
  • PubMed
  • Google Scholar

Cited By...

  • Transcriptomic signatures of A{beta}- and tau-induced neuronal dysfunction reveal inflammatory processes at the core of Alzheimers disease pathophysiology
  • Diagnostic accuracy of the plasma ALZpath pTau217 immunoassay to identify Alzheimers disease pathology
  • The Association of Age-Related and Off-Target Retention with Longitudinal Quantification of [18F]MK6240 Tau PET in Target Regions
  • Revealing the combined roles of A{beta} and tau in Alzheimers disease via a pathophysiological activity decoder
  • Performance of plasma amyloid, tau, and astrocyte biomarkers to identify cerebral AD pathophysiology
  • Astrocyte biomarker signatures of amyloid-{beta} and tau pathologies in Alzheimers disease
  • Google Scholar

More in this TOC Section

Neurology

  • Dopamine D1 Receptor Agonist PET Tracer Development: Assessment in Nonhuman Primates
  • Hypermetabolism on Pediatric PET Scans of Brain Glucose Metabolism: What Does It Signify?
  • TauIQ: A Canonical Image Based Algorithm to Quantify Tau PET Scans
Show more Neurology

Clinical

  • Detection of Early Progression with 18F-DCFPyL PET/CT in Men with Metastatic Castration-Resistant Prostate Cancer Receiving Bipolar Androgen Therapy
  • TauIQ: A Canonical Image Based Algorithm to Quantify Tau PET Scans
  • Dual PET Imaging in Bronchial Neuroendocrine Neoplasms: The NETPET Score as a Prognostic Biomarker
Show more Clinical

Similar Articles

Keywords

  • Alzheimer disease
  • amyloid-β
  • PET
  • 18F-AZD4694
SNMMI

© 2025 SNMMI

Powered by HighWire